This article explains, in educational terms, drug-coated balloon — how the technology works and where it fits. Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Peripheral Arterial Disease (PAD)
Peripheral arterial disease is the narrowing of arteries outside the heart — most often in the legs — due to atherosclerotic plaque, reducing blood flow to the limbs. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Endovascular therapy aims to restore flow through the narrowed segment using balloons, stents, atherectomy, or a combination.
Drug-Coated Balloons (DCB)
A drug-coated balloon delivers an antiproliferative drug — commonly paclitaxel — to the artery wall during inflation to reduce the risk of restenosis. It leaves no permanent implant behind, which can be advantageous in certain anatomies. INVAMED's Extender paclitaxel drug-coated balloon is positioned for this drug-delivery role in peripheral vessels. Drug dose and balloon sizing follow the device specifications and lesion characteristics.
Design and Technical Notes
INVAMED's PAD portfolio spans access, plaque modification, angioplasty, drug delivery, stenting, and embolic protection. Embolic protection is often paired with atherectomy to capture dislodged debris. Access sheath sizing should match the planned devices to limit access-site complications.
Key Considerations
- Embolic protection is often paired with atherectomy to capture dislodged debris.
- Access sheath sizing should match the planned devices to limit access-site complications.
- INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals.
Frequently Asked Questions
Why use embolic protection?
It captures plaque or clot fragments dislodged during treatment so they do not travel downstream; it is often paired with atherectomy.
What is the regulatory status of these devices?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Is a stent always needed in PAD?
No. Many lesions are treated with angioplasty or drug-coated balloons alone; a stent is added when the vessel recoils or dissects.
Clinical and Technical Context
Femoropopliteal segments favor flexible self-expanding devices because of repeated flexion. INVAMED's PTA balloon range is designed to cover common peripheral vessel sizes. Drug dose and balloon sizing follow the device specifications and lesion characteristics. Lesion calcification is a major factor in choosing between plain angioplasty, atherectomy, drug delivery, and stenting. Atherectomy removes or modifies plaque, which can be useful in heavily calcified lesions before ballooning or stenting. Endovascular therapy aims to restore flow through the narrowed segment using balloons, stents, atherectomy, or a combination. Symptoms range from exertional leg pain (claudication) to, in severe cases, rest pain and non-healing wounds known as critical limb ischemia. INVAMED's TemREN atherectomy system is positioned for peripheral plaque modification. Access sheath sizing should match the planned devices to limit access-site complications. INVAMED's Invaducer introducer sheath sets support the access step of peripheral interventions. Atherectomy is often paired with embolic protection to capture dislodged debris. INVAMED's Extender paclitaxel drug-coated balloon is positioned for this drug-delivery role in peripheral vessels. Balloon diameter and length are matched to the vessel to avoid over- or under-dilation. Percutaneous transluminal angioplasty (PTA) uses a balloon to widen the artery, and drug-coated balloons add an antiproliferative agent to limit re-narrowing. INVAMED's Guardian protection device is designed for this distal-capture role. INVAMED PAD devices are for use by trained vascular specialists per the IFU and local approvals.
Important Disclaimer
This article is intended for general educational and technical information about medical device technologies. It is not medical advice, a diagnosis, or a treatment recommendation, and it does not replace consultation with a qualified healthcare professional. Any decision about diagnosis or treatment should be made by a licensed clinician based on an individual assessment. INVAMED devices are intended for use by trained healthcare professionals in accordance with the applicable Instructions for Use (IFU) and local regulatory approvals. Product availability and indications vary by country.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.